Paige Malick
Physician Assistant · Orlando, FLNPI 1083213102
Payments from drug & device makers
Across 221 payments — averaging $22.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$889
- AbbVie$514
- Lilly USA, LLC$343
- GSK$330
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$256
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,984100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 31 | $1,069 |
| Novo Nordisk | 47 | $889 |
| AbbVie | 24 | $514 |
| Lilly USA, LLC | 13 | $343 |
| GSK | 21 | $330 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $256 |
| Amgen | 8 | $250 |
| Otsuka America Pharmaceutical, Inc. | 12 | $235 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $223 |
| Pfizer | 8 | $150 |
| Abbott | 1 | $146 |
| Medtronic | 2 | $106 |
| Corcept Therapeutics | 4 | $91 |
| Exact Sciences | 3 | $67 |
| Ardelyx, Inc. | 2 | $45 |
| Merck | 2 | $40 |
| Boehringer Ingelheim | 2 | $31 |
| Sanofi | 1 | $28 |
| Seqirus USA Inc | 1 | $27 |
| Bayer | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Intra-sana Laboratories | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Optinose US, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,984 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 89 | $96,975 |
| OzempicSemaglutide | 61 | $76,214 |
| JanumetSitagliptin Phos/Metformin Hcl | 26 | $28,669 |
| JardianceEmpagliflozin | 24 | $26,214 |
| EliquisApixaban | 27 | $20,144 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $19,489 |
| TrulicityDulaglutide | 20 | $19,287 |
| MounjaroTirzepatide | 16 | $18,608 |
| Tresiba Flextouch U-200Insulin Degludec | 25 | $17,947 |
| TradjentaLinagliptin | 16 | $17,469 |
| JanuviaSitagliptin Phosphate | 11 | $17,313 |
| LinzessLinaclotide | 16 | $15,101 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $12,849 |
| GlyxambiEmpagliflozin/Linagliptin | 14 | $10,646 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 11 | $8,889 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $1,069 | $109,824107 claims |
| Novo NordiskOzempic | $889 | $76,21461 claims |
| MerckJanumet, Januvia, Janumet Xr | $40 | $54,87148 claims |
| Boehringer IngelheimJardiance, Tradjenta, Glyxambi | $31 | $54,32854 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $343 | $37,89536 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $330 | $24,70533 claims |
| PfizerEliquis | $150 | $20,14427 claims |
| AbbVieLinzess | $514 | $15,10116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Orlando
- Risha BellomoOrlando$397K
- Nicole HillOrlando$319K
- Gina ManginOrlando$300K
- Brandon NievesOrlando$235K
- Nancy MimbsOrlando$118K
- Daniel HendricksOrlando$53K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.